Opioid prescribing and consumption after head and neck free flap reconstruction: what is the evidence for multimodal analgesia?
Journal of Oral and Maxillofacial Anesthesia · 2022
DOI: 10.21037/joma-21-19 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Oral and Maxillofacial Anesthesia, 2022. Verfasst von John D Cramer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Wayne State University School of Medicine, Detroit, MI, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
All opioids carry a risk of dependence, substance use disorder, and fatal overdose (1), and risk increases in proportion to the duration of opioid exposure (2). For patients with advanced head and neck cancer requiring ablative surgery and microvascular free tissue reconstruction, the risk of developing opioid use disorder is amplified by both the complexity of treatment and the prolonged recovery often required. Chronic opioid use is reported by 41–64% of head and neck cancer patients at 3 months after treatment (3,4). Although some patients receive opioid analgesia preoperatively for cancer-related pain, many patients undergoing head and neck cancer surgery have their initial exposure to opioids during or after surgery. In recent years, a growing number of investigators have investigated strategies to minimize persistent opioid use in this patient population, with an emphasis on opioid-sparing or reducing regimens.
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Wayne State University School of Medicine, Detroit, MI, USA.
- Bert N LaDu Professor of Anesthesiology, Michigan Opioid Prescribing Engagement Network, Ann Arbor, MI, USA.
- University of Michigan, Department of Anesthesiology, Ann Arbor, MI, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
Förderung
- NIDA NIH HHS
Zitieren
APA
Cramer, J. D., Brummett, C. M., & Brenner, M. J. (2022). Opioid prescribing and consumption after head and neck free flap reconstruction: what is the evidence for multimodal analgesia?. Journal of Oral and Maxillofacial Anesthesia. https://doi.org/10.21037/joma-21-19
Vancouver
Cramer JD, Brummett CM, Brenner MJ. Opioid prescribing and consumption after head and neck free flap reconstruction: what is the evidence for multimodal analgesia?. Journal of Oral and Maxillofacial Anesthesia. 2022. doi:10.21037/joma-21-19
BibTeX
@article{Cramer2022,
author = {Cramer, John D and Brummett, Chad M and Brenner, Michael J},
title = {Opioid prescribing and consumption after head and neck free flap reconstruction: what is the evidence for multimodal analgesia?},
journal = {Journal of Oral and Maxillofacial Anesthesia},
year = {2022},
doi = {10.21037/joma-21-19}
}
EUVIMED